Ligand Pharmaceuticals | LGND - Current Assets

Stock Price
196.51
Daily Change
-1.42 -0.72%
Monthly
2.33%
Yearly
67.58%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $753.92M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Amgen USD 27.88B 1.15B Sep/2025
Arrowhead Research USD 950.64M 3.72M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Glaxosmithkline GBP 23.98B 6.31B Sep/2025
Insmed USD 1.93B 149.77M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Ligand Pharmaceuticals USD 753.92M 400.98M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Veracyte USD 449.22M 34.54M Sep/2025